Pharmafile Logo

News and Press Releases

BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology

Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026

BRAINBiotech
public@brain-biotech.com
Darmstädter Straße 34 – 36 64673 Zwingenberg Deutschland

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision 10 March 2026 -- Colorado, US -- Cirena has secured a license to the...

Category: Biotechnology, Drug Discovery, Manufacturing and Packing, Other
Posted: March 10, 2026

Cirena
rnatechsupport@cirena.com
3415 Colorado Avenue Boulder, CO 80303

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement

License agreement provides Université de Montréal access to CRISPR gene editing technology for use across its platform services 1 October 2024 -- Dublin, Ireland, and Montreal, Canada -- ERS Genomics...

Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 1, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement

Partnership provides Medicines Discovery Catapult access to CRISPR gene editing technology across a broad range of drug discovery applications 04 September 2024 – Dublin, Ireland, and Cheshire, UK – ERS...

Category: BioManufacturing
Posted: September 9, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

License agreement provides IRBM access to CRISPR gene editing technology to be applied across its drug discovery services offering 20 May 2024 -- Dublin, Ireland, and Rome, Italy -- ERS...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: May 20, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

ERS Genomics appoints John E Milad as Chief Executive Officer

13 May 2024 -- Dublin, Ireland -- ERS Genomics, the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25...

Category: Drug Delivery, Drug Discovery
Posted: May 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model 13 March 2024 -- Tokyo, Japan, and Dublin, Ireland -- Ricoh Company today announced a...

Category: Biotechnology
Posted: March 13, 2024

ERS Genomics
8th Floor, Block E, Iveagh Court, Harcourt Road, Dublin D02 YT22, Ireland

Broken String Biosciences’ INDUCE-seq platform demonstrates impact of structural DNA changes on specificity of CRISPR-Cas9 gene editing

Research published in Molecular Cell used INDUCE-seq to identify DNA topology as an important regulator of CRISPR targeting specificity Peer-reviewed data demonstrates the sensitivity of INDUCE-seq DNA break mapping platform,...

Category: Biotechnology
Posted: October 18, 2023

Broken String Biosciences
info@brokenstringbio.com
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR